Call us harman

(888-554-2762)

PRACTICE AREAS CONTACT

Harman Law LLC
4279 Roswell Road
Suite 102-273
Atlanta, GA 30342

404-869-1119 (main)
888-554-2762 (toll free)

info@harmanlaw.com

Latest News

Product Liability Latest News
Pharmaceutical Latest News
Medical Device Latest News
Personal Injury Latest News
Consumer Fraud Latest News
Insurance Bad Faith Latest News
Toxic Exposure Latest News
Unfair Business Practice Latest News
Whistleblower Latest News
Wrongful Death Latest News
All Latest News



About Harman Law LLC
Harman Law LLC is a national law firm that fights for justice for those who have been harmed – physically or financially – by someone who refuses to do what’s right.   Contact us today by filling out a questionnaire, or by calling our toll free number (1-888-554-4672) for a no-cost no-obligation preliminary evaluation of your case.
LATEST NEWS

Harman Appearing on The American Law Journal from CNN Atlanta

Attorney Matthew Harman, Atlanta, GAFrom the CNN Atlanta studios, Attorney Matthew Harman will appear on the legal television program The American Law Journal discussing the U.S. Food and Drug Administration.

The program will air on the Philadelphia CNN-News affiliate WFMZ Monday May 13, 2013 at 7:00 p.m., the following Sunday May 19 at 5:30 p.m., and online at www.YouTube.com/LawJournalTV.

Enhanced by Zemanta

Read more

Medtronic Drug Infusion Pump Failures and Recall

The FDA has notified healthcare professionals that Medtronic Drug Infusion Pumps could fail if they are used with drugs not approved for the devices. The consequences could be severe adverse health events including death.

When medications used in the pump are not approved for the device, the motor may stall intermittently or fail permanently, ceasing the infusion of drugs as prescribed. Patients may not be aware the pump has failed until they experience a potentially serious medical issue.

The Medtronic recalled implantable drug infusion pump models are:

  • SynchroMed II
  • SynchroMed EL

The FDA says this Class 1 recall is the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

Our firm is investigating cases nationwide where these pumps may be responsible for injury or death.

If you or someone you know has one of these pumps and experienced a failure or other problem, contact our office immediately by filling out the brief questionnaire or call 888-554-2762 for a free consultation and evaluation of your situation. You may be eligible for compensation.

As with any medical issue, if you currently experiencing side effects consult your healthcare professional immediately.

 

Links

Medtronic Recalls Drug Pumps After Infusion Failures“, Bloomberg News, Dec. 21, 2012

Medtronic Drug Infusion Pumps: Recall – Intermittent or Permanent Pump Motor Stall“, U.S. Food and Drug Administration, December 21, 2012

 

Enhanced by Zemanta

Read more

Parents of Premature Babies in Oxygen Research Study Not Warned of Risks

Parents of premature babies in a four-year study of oxygen level treatment were not sufficiently warned  of the potential dangers of the experiments. The families of over one thousand babies could have been at risk of blindness, brain damage or death as a consequence of their participation in the research.

The U.S. Department of Health and Human Services criticized lead researchers at the nearly two dozen participating medical schools for inadequate informed consent. Emory University Medical School in Atlanta participated in the study.

The attorneys at Harman Law Firm are investigating any harm to babies that may have occurred during their involvement in the research. If you or a family you know has an infant who was in the study at Emory or any research center who experienced a health problem contact our firm immediately to learn your options and protect the child’s health in the future. Fill out our contact form, email info@harmanlaw.com, or call toll-free 888-554-2762.
Links

Parents Not Warned of Risk in Premature Infants Study,” The Boston Globe, April 11, 2013

Feds Say Study of Babies at UM, Elsewhere Should Have Disclosed Risks,” The Miami Herald, April 10, 2013

Study of Babies Did Not Disclose Risks, U.S. Finds,” The New York Times, April 10, 2013

VIDEO: “Inadequate Consent in Premie Study,” Democrat and Chronicle/Gannett News, April 11, 2013

Enhanced by Zemanta

Read more

Birth Defects

Many medications have been linked to serious birth defects.

These birth defects include:

Heart Defects

Atrial septal defect (ASD)

Hypoplastic left heart syndrome (HLHS)

Hypoplastic right heart syndrome

Transposition of the great arteries (TGA)

Coarctation of the aorta (CoA)

Tetralogy of Fallot (TOF)

Pulmonary atresia

Aortic stenosis

Patent ductus arteriosus (PDA)

Ventricular septal defect (VSD)

Patent foramen ovale (PFO)

Pulmonary valve stenosis

Truncus arteriosus

Tricuspid atresia

Tricuspid valve – Ebstein’s anomaly

Atrioventricular canal defect

Congenital heart disease

Lung Defects

Primary pulmonary hypertension (PPHN)

Pulmonary stenosis

Cranial Defects

Craniosynostosis – cranial skull defect

Abdominal Wall Defects

Omphalocele

Gastroschisis

If you or a loved one gave birth to a child with a birth defect, please contact us immediately.

Read more

Hip & Knee Implants Failing

If you have a knee or hip implant, please contact us to see if you are entitled to compensation.

Read more

© 2010 Harman Law LLC, All Rights Reserved.
Website by: YDO
This website is designed for general information only.  The information contained on this site does not constitute legal advice and does not form an attorney-client relationship.